Company profile CUE
After 39 days of this quarter the interest is at 37.0. Based on that we can calculate that during remaining 52 days it will total up to 86.0. Cue Biopharma expected interest is significantly lower compared to previous quarter (-77.2%) and same quarter last year (-52.7%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 135 | 323 139.3% QoQ | 97 -70.0% QoQ | 171 76.3% QoQ |
| 2020 | 440 225.9% YoY 157.3% QoQ | 392 21.4% YoY -10.9% QoQ | 158 62.9% YoY -59.7% QoQ | 245 43.3% YoY 55.1% QoQ |
| 2021 | 207 -53.0% YoY -15.5% QoQ | 267 -31.9% YoY 29.0% QoQ | 421 166.5% YoY 57.7% QoQ | 209 -14.7% YoY -50.4% QoQ |
| 2022 | 181 -12.6% YoY -13.4% QoQ | 142 -46.8% YoY -21.5% QoQ | 328 -22.1% YoY 131.0% QoQ | 159 -23.9% YoY -51.5% QoQ |
| 2023 | 182 0.6% YoY 14.5% QoQ | 127 -10.6% YoY -30.2% QoQ | 297 -9.5% YoY 133.9% QoQ | 377 137.1% YoY 26.9% QoQ |
| 2024 | 37 -79.7% YoY -90.2% QoQ | - | - | - |
The average 5 years interest of Cue Biopharma was 18.75 per week. The last year interest of Cue Biopharma compared to the last 5 years has changed by 2.99%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 15.84%.
There is not enough data for CUE-101 clinical trial to provide analysis
There is not enough data for CUE-101 clinical trial to provide correlation calculation
There is not enough data for CUE-101 clinical trial to provide analysis
After 34 days of this quarter the interest is at 310.0. Based on that we can calculate that during remaining 58 days it will total up to 839.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 493 |
| 2019 | 730 48.1% QoQ | 709 -2.9% QoQ | 661 -6.8% QoQ | 658 33.5% YoY -0.5% QoQ |
| 2020 | 690 -5.5% YoY 4.9% QoQ | 578 -18.5% YoY -16.2% QoQ | 604 -8.6% YoY 4.5% QoQ | 559 -15.0% YoY -7.5% QoQ |
| 2021 | 610 -11.6% YoY 9.1% QoQ | 635 9.9% YoY 4.1% QoQ | 626 3.6% YoY -1.4% QoQ | 670 19.9% YoY 7.0% QoQ |
| 2022 | 764 25.2% YoY 14.0% QoQ | 843 32.8% YoY 10.3% QoQ | 769 22.8% YoY -8.8% QoQ | 735 9.7% YoY -4.4% QoQ |
| 2023 | 827 8.2% YoY 12.5% QoQ | 806 -4.4% YoY -2.5% QoQ | 785 2.1% YoY -2.6% QoQ | 310 -57.8% YoY -60.5% QoQ |
The average 5 years interest of Cancer immunotherapy was 53.88 per week. The last year interest of Cancer immunotherapy compared to the last 5 years has changed by 12.75%. The interest for Cancer immunotherapy is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 12.46%.
After 39 days of this quarter the interest is at 293.0. Based on that we can calculate that during remaining 52 days it will total up to 684.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 327 | 623 90.5% QoQ | 482 -22.6% QoQ | 492 2.1% QoQ |
| 2020 | 637 94.8% YoY 29.5% QoQ | 528 -15.2% YoY -17.1% QoQ | 533 10.6% YoY 0.9% QoQ | 593 20.5% YoY 11.3% QoQ |
| 2021 | 590 -7.4% YoY -0.5% QoQ | 631 19.5% YoY 6.9% QoQ | 710 33.2% YoY 12.5% QoQ | 482 -18.7% YoY -32.1% QoQ |
| 2022 | 727 23.2% YoY 50.8% QoQ | 661 4.8% YoY -9.1% QoQ | 730 2.8% YoY 10.4% QoQ | 705 46.3% YoY -3.4% QoQ |
| 2023 | 860 18.3% YoY 22.0% QoQ | 909 37.5% YoY 5.7% QoQ | 798 9.3% YoY -12.2% QoQ | 890 26.2% YoY 11.5% QoQ |
| 2024 | 293 -65.9% YoY -67.1% QoQ | - | - | - |
The average 5 years interest of Autoimmune disease treatment was 50.58 per week. The last year interest of Autoimmune disease treatment compared to the last 5 years has changed by 28.67%. The interest for Autoimmune disease treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 56.37%.
After 34 days of this quarter the interest is at 49.0. Based on that we can calculate that during remaining 58 days it will total up to 133.0. Biologics development expected interest is significantly lower compared to same quarter last year (-58.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 59 |
| 2019 | 265 349.2% QoQ | 0 -100.0% QoQ | 260 inf% QoQ | 130 120.3% YoY -50.0% QoQ |
| 2020 | 166 -37.4% YoY 27.7% QoQ | 200 inf% YoY 20.5% QoQ | 261 0.4% YoY 30.5% QoQ | 89 -31.5% YoY -65.9% QoQ |
| 2021 | 80 -51.8% YoY -10.1% QoQ | 144 -28.0% YoY 80.0% QoQ | 122 -53.3% YoY -15.3% QoQ | 210 136.0% YoY 72.1% QoQ |
| 2022 | 244 205.0% YoY 16.2% QoQ | 171 18.8% YoY -29.9% QoQ | 383 213.9% YoY 124.0% QoQ | 317 51.0% YoY -17.2% QoQ |
| 2023 | 154 -36.9% YoY -51.4% QoQ | 278 62.6% YoY 80.5% QoQ | 198 -48.3% YoY -28.8% QoQ | 49 -84.5% YoY -75.3% QoQ |
The average 5 years interest of Biologics development was 14.54 per week. The last year interest of Biologics development compared to the last 5 years has changed by 14.65%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 40.32%.
There is not enough data for Tumor-specific T cells to provide analysis
There is not enough data for Tumor-specific T cells to provide correlation calculation
There is not enough data for Tumor-specific T cells to provide analysis
There is not enough data for Cue Biopharma stock price to provide analysis
There is not enough data for Cue Biopharma stock price to provide correlation calculation
There is not enough data for Cue Biopharma stock price to provide analysis
There is not enough data for Cue Biopharma Boston to provide analysis
There is not enough data for Cue Biopharma Boston to provide correlation calculation
There is not enough data for Cue Biopharma Boston to provide analysis
After 92 days of this quarter the interest is at 36.0. Based on that we can calculate that during remaining 0 days it will total up to 36.0. Cue Biopharma -stock -company expected interest is significantly lower compared to previous quarter (-79.4%) and same quarter last year (-58.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 137 |
| 2019 | 363 165.0% QoQ | 197 -45.7% QoQ | 394 100.0% QoQ | 156 13.9% YoY -60.4% QoQ |
| 2020 | 149 -59.0% YoY -4.5% QoQ | 299 51.8% YoY 100.7% QoQ | 305 -22.6% YoY 2.0% QoQ | 118 -24.4% YoY -61.3% QoQ |
| 2021 | 134 -10.1% YoY 13.6% QoQ | 326 9.0% YoY 143.3% QoQ | 212 -30.5% YoY -35.0% QoQ | 198 67.8% YoY -6.6% QoQ |
| 2022 | 255 90.3% YoY 28.8% QoQ | 170 -47.9% YoY -33.3% QoQ | 86 -59.4% YoY -49.4% QoQ | 142 -28.3% YoY 65.1% QoQ |
| 2023 | 195 -23.5% YoY 37.3% QoQ | 175 2.9% YoY -10.3% QoQ | 36 -58.1% YoY -79.4% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of Cue Biopharma -stock -company was 15.57 per week. The last year interest of Cue Biopharma -stock -company compared to the last 5 years has changed by -32.31%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -49.76%.